Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis

Chia Siang Kow; Syed Shahzad Hasan

doi:10.1007/s11239-021-02436-0

Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis

Chia Siang Kow, Syed Shahzad Hasan

Research output: Contribution to journal › Letter › peer-review

29 Citations (Scopus)

Abstract

Globally, there have been close to 130 million reported cases of coronavirus disease 2019 (COVID-19) as of 2nd April 2021, with 2.8 million deaths documented [1]. In order to reduce the risk of mortality associated with COVID19, several drugs have been repurposed for its treatment.

Original language	English
Pages (from-to)	124-129
Number of pages	6
Journal	Journal of Thrombosis and Thrombolysis
Volume	52
Issue number	1
Early online date	4 Apr 2021
DOIs	https://doi.org/10.1007/s11239-021-02436-0
Publication status	Published - 1 Jul 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s11239-021-02436-0Licence: Other

Cite this

@article{816eba1136bc4e08a6e52c3ffc3dff77,

title = "Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis",

abstract = "Globally, there have been close to 130 million reported cases of coronavirus disease 2019 (COVID-19) as of 2nd April 2021, with 2.8 million deaths documented [1]. In order to reduce the risk of mortality associated with COVID19, several drugs have been repurposed for its treatment. ",

keywords = "COVID-19, Antiplatelet drugs",

author = "Kow, {Chia Siang} and Hasan, {Syed Shahzad}",

year = "2021",

month = jul,

day = "1",

doi = "10.1007/s11239-021-02436-0",

language = "English",

volume = "52",

pages = "124--129",

journal = "Journal of Thrombosis and Thrombolysis",

issn = "0929-5305",

publisher = "Springer Netherlands",

number = "1",

}

TY - JOUR

T1 - Use of antiplatelet drugs and the risk of mortality in patients with COVID-19

T2 - a meta‐analysis

AU - Kow, Chia Siang

AU - Hasan, Syed Shahzad

PY - 2021/7/1

Y1 - 2021/7/1

N2 - Globally, there have been close to 130 million reported cases of coronavirus disease 2019 (COVID-19) as of 2nd April 2021, with 2.8 million deaths documented [1]. In order to reduce the risk of mortality associated with COVID19, several drugs have been repurposed for its treatment.

AB - Globally, there have been close to 130 million reported cases of coronavirus disease 2019 (COVID-19) as of 2nd April 2021, with 2.8 million deaths documented [1]. In order to reduce the risk of mortality associated with COVID19, several drugs have been repurposed for its treatment.

KW - COVID-19

KW - Antiplatelet drugs

UR - http://www.scopus.com/inward/record.url?scp=85103627273&partnerID=8YFLogxK

U2 - 10.1007/s11239-021-02436-0

DO - 10.1007/s11239-021-02436-0

M3 - Letter

C2 - 33813716

VL - 52

SP - 124

EP - 129

JO - Journal of Thrombosis and Thrombolysis

JF - Journal of Thrombosis and Thrombolysis

SN - 0929-5305

IS - 1

ER -

Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this